RecruitingNCT07007585

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection: A Prospective Observational Study


Sponsor

Jose Ivan Rodriguez de Molina Serrano

Enrollment

100 participants

Start Date

Aug 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.


Eligibility

Min Age: 5 Years

Inclusion Criteria4

  • Patients aged ≥5 years
  • Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
  • First contact at emergency or outpatient services
  • Informed consent signed by the patient or legal guardian

Exclusion Criteria3

  • Co-infection with other arboviruses or COVID-19
  • Pre-existing hematologic or oncologic disease
  • Refusal to sign informed consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Clinica Mexico

Piedras Negras, Coahuila, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07007585


Related Trials